Introduction of referent prices will let to reduce the cost of medicines for hypertensive patients by 25-30%, head of the State service on medicines Oleksiy Solovyov told a briefing, ForUm correspondent reports.

According to the official, nine international unpatented medicines against hypertension will be sold at referent prices. "Such measures will let seven million people suffering hypertension to save about 200 million hryvnias annually," he explained.

Solovyov added that it is also planned to continue this pilot project and to introduce referent prices for other medicines.


Спасибо за Вашу активность, Ваш вопрос будет рассмотрен модераторами в ближайшее время